Search
Regulatory Story
Company Consort Medical PLC
TIDM CSRT
Headline Director/PDMR Shareholding
Released 07:00 25-Jul-2019
Number 6366G07

RNS Number : 6366G
Consort Medical PLC
25 July 2019
 

25 July 2019

 

Consort Medical plc

 

Notification of Transactions of Directors or

Persons Discharging Managerial Responsibility and Connected Persons

 

 

 

On 24 July 2019, pursuant to the rules of the Consort Medical plc Deferred Bonus Plan, the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares in the Company ("Ordinary Shares") at a share price of £7.85 each as detailed below:

 

 

Deferred Bonus Share Award (in respect of the financial year 2018/19)

 

Director/PDMR

Number of Ordinary Shares awarded

Jonathan Glenn

17,216

Paul Hayes

9,966

Keyvan Djamarani

5,985

Manja Boerman

3,840

 

 

Each award was granted as a nil cost option.

 

Enquiries:           Andrew Jackson, Company Secretary     01442 867920

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jonathan Glenn

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP)

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

0

17,216

 

 


 

 

 

 

d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

24 July 2019

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Keyvan Djamarani

2

 

Reason for the notification

 

a)

 

Position/status

 

 

President Bespak

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan

 

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

0

5,985

 


 

 

 

 

d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

 24 July 2019

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Manja Boerman

2

 

Reason for the notification

 

a)

 

Position/status

 

 

President Aesica

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the  Consort Medical Deferred Bonus Plan (DBP)

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

0

3,840

 


 

 

 

 

d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

 24 July 2019

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Hayes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP)

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

0

9,966

 


 

 

 

 

d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

24 July 2019

f)

 

Place of the transaction

 

Off market transaction

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZLFLKDFBBBZ
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.